Embolx
  • Home
  • About Us
  • Products
  • Resources
  • News
  • Clinical Evidence
    • Cases
    • Publications
    • Webinars
    • White Papers
  • Careers
  • Contact Us
Select Page
National Institute of Health Awards Embolx Phase II SBIR Grant for Further Development of Pressure – Directed Embolization Therapy

National Institute of Health Awards Embolx Phase II SBIR Grant for Further Development of Pressure – Directed Embolization Therapy

Feb 2, 2018 | Press Release

SUNNYVALE, Calif.–(BUSINESS WIRE)–Embolx, Inc., a medical device company, announced today that the Company has been awarded a Small Business Innovation Research (SBIR) grant valued at $2 million from the National Cancer Institute (NCI) of the National...

Recent Posts

  • New Revolutionary Treatment for Live Cancers
  • National Institute of Health Awards Embolx Phase II SBIR Grant for Further Development of Pressure – Directed Embolization Therapy
  • National Institute of Health Awards Embolx Phase II SBIR Grant for Further Development of Pressure – Directed Embolization Therapy

Recent Comments

    Archives

    • June 2018
    • April 2018
    • February 2018

    Categories

    • Press Release
    • WIVB | Buffalo

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    ©Copyright 2020 Embolx, Inc. All rights reserved. Sniper is a registered trademark of Embolx, Inc. in the United States.